[Clinical study on effect of kang' aibao oral liquid in treating 103 malignant tumor patients]

Zhongguo Zhong Xi Yi Jie He Za Zhi. 1997 Dec;17(12):730-2.
[Article in Chinese]


Objective: To observe the clinical efficacy of Kangaibao oral liquid(KABOL), a Chinese herbal preparation in treating malignant turmor of middle or advanced stage.

Methods: A comparative study was done by observing the effect of 103 patients treated with KABOL, and another 90 patients treated with chemotherapy in the same period were taken as a control group for comparison.

Results: The immunologic function, short-term effective rate (complete relieved rate and partial relieved rate), survival quality, 1-, 2- and 3-year survival rate, median suvival time, and the CEA declining rate of the KABOL group were significantly higher than those of the control group.

Conclusions: KABOL has the effects of inhibiting tumor growth, prolonging the survival time and improving the quality of survival of tumor patient.

Publication types

  • Clinical Trial
  • Comparative Study
  • English Abstract
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cisplatin / administration & dosage
  • Drugs, Chinese Herbal / therapeutic use*
  • Esophageal Neoplasms / drug therapy*
  • Esophageal Neoplasms / mortality
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / mortality
  • Male
  • Middle Aged
  • Stomach Neoplasms / drug therapy
  • Stomach Neoplasms / mortality
  • Survival Rate


  • Antineoplastic Agents, Phytogenic
  • Drugs, Chinese Herbal
  • Cisplatin
  • Fluorouracil